Splash Beverage Group’s Pulpoloco to be Available in Participating 7-Eleven and Speedway Stores
Splash Beverage Group, Inc. (NYSE American: SBEV) previously announced that Pulpoloco was awarded the 7-Eleven, Inc. Brands with Heart™ designation and with that designation the opportunity to showcase the brand to 7-Eleven® and Speedway® stores.
Brüush to Continue to Disrupt At-Home Oral Care with Upcoming New Products
After setting out to disrupt the oral care category with its sonic-powered electric toothbrush and brush head refill subscription plan, the Company announced today that it is on track to expand its product lineup.
CEO Interview: $BRSH
Brüush Oral Care, Inc. (NASDAQ: BRSH) is an exciting oral care-based subscription service offering sleekly designed electric toothbrushes at a competitive price. The company has grown to 38,000 subscribers and has plans to expand its products into “owning the bathroom”, making it an exciting...
OKYO Pharma Limited Prices $5.3 Million Offering of ADSs
OKYO Pharma Limited (Nasdaq: OKYO, LSE: OKYO) (“OKYO Pharma” or the “Company“), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases (“DED”) and ocular pain, announced the pricing of a reasonable best efforts public...
CEO INTERVIEW: OKYO
OKYO CEO Interview Gary Jacob, PHD.
DSS Announces Letter to Shareholders
DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to enrich shareholder value, today announced a letter to shareholders.
OKYO Pharma: An Emerging Biopharma Smallcap With Game Changing Treatments In Ophthalmology
OKYO Pharma's main drug has already surpassed Phase 1 and reached Phase 2. OK-101 is catering to niches within the domain of ophthalmic diseases and is expected to see its core drug candidate in Phase 2 of clinical trials in the very near future.